Luke Scanlan

Mr. Luke Scanlan


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2024 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
OSOm Vishwas Sakhalkar
Om Vishwas Sakhalkar
LSLuke Scanlan
Luke Scanlan
ZKZachary Klaassen
Zachary Klaassen
SKSherita A King
Sherita A King
MSMatthew N Simmons
Matthew N Simmons
PSPablo J SantaMaria
Pablo J SantaMaria
Rezūm is a relatively new, minimally invasive approach that utilizes vaporized water to ablate prostatic tissue surrounding the proximal urethra in patients with benign prostatic hyperplasia. However, of the many notable studies involving Rezūm’s effectiveness in men, none have documented use of Rezūm in the transgender community. With a growing population of transgender patients in the USA, prostate treatments will be offered for transgender women on a more regular basis. To the best of our knowledge, we introduce the first case of Rezūm being utilized to treat benign prostatic hyperplasia in a patient self-identifying as a woman.